checkAd

    DGAP-News  748  0 Kommentare STRATEC - Results for 1st Half of 2016 and new Financial Guidance - Seite 2


    April 1 to June 30, 2016. Following a gradual start in the first quarter,
    the second quarter brought a more notable increase in the systems
    delivered, especially those established at STRATEC's partners. The call-up
    figures in Asia reported in the first quarter by one customer have now
    stabilized at the level seen in the first three months. Organic second-
    quarter sales (excluding sales at acquired companies) grew year-on-year by
    2.5% to EUR 36.3 million.

    Six-month EBIT rose 5.3% to EUR 12.6 million. Due to the benefits of scale
    taking effect once again in the second quarter, the Group achieved an
    organic EBIT margin of 17.5%. The EBIT margin for the first half of 2016
    came to 16.2%. The non-recurring items excluded for comparison include
    transaction and integration expenses of EUR 1.2 million and write-downs of
    EUR 1.5 million recognized upon the purchase price allocation for the
    Diatron Group.

    In addition, the second quarter of 2016 saw the recognition of non-
    recurring items, amounting to EUR 1.4 million, arising from the near
    complete external tax audit for the periods from 2009 to 2013. Excluding
    this item, consolidated net income for the first half amounted to EUR 10.3
    million and was a 5.1% increase on the previous year's equivalent figure.
    As a result, earnings per share rose by 5.3% to EUR 0.87 (previous year:
    EUR 0.83).

    Following the distribution in June of EUR 8.9 million in dividends,
    outflows of around EUR 97 million for two company acquisitions, and the
    commencement of EUR 68 million in short-term loans, cash and cash
    equivalents came to EUR 22.4 million at the reporting date on June 30,
    2016.

    The equity ratio of STRATEC AG amounted to 53.2% as of June 30, 2016. The
    bridge financing taken up for the acquisitions is to be converted before
    the end of the year into medium to long-term financing facilities.

    Financial forecast
    For the 2016 financial year as a whole, STRATEC expects its sales -
    following the time-apportioned consolidation of Diatron and STRATEC
    Consumables - to increase to between EUR 175 million and EUR 182 million,
    with an EBIT margin (excluding acquisition and integration expenses) of
    16.0% to 17.5%. In the 2017 financial year, the two companies acquired will
    be consolidated in the STRATEC Group for the first time for a full
    reporting period. Excluding further acquisitions, sales are expected to
    rise to between EUR 205 million and EUR 220 million, with a slight increase
    in the EBIT margin compared with 2016.

    According to its most recent financial forecast, STRATEC expects its
    average annual sales growth, excluding newly acquired companies, to amount
    Seite 2 von 4


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News STRATEC - Results for 1st Half of 2016 and new Financial Guidance - Seite 2 DGAP-News: STRATEC Biomedical AG / Key word(s): Half Year Results/Interim Report STRATEC - Results for 1st Half of 2016 and new Financial Guidance 21.07.2016 / 07:45 The issuer is solely responsible for the content of this announcement. …

    Schreibe Deinen Kommentar

    Disclaimer